Search
Biospace news
RSS Feed for Biotech, Pharmaceutical and Clinical Research News | BioSpace (Generated by New Sloth)
Updated: 18 hours 49 min ago
Gilead’s Magrolimab Ineffective, Linked to Increase Risk of Death in MDS Patients
Gilead’s Magrolimab Ineffective, Linked to Increase Risk of Death in MDS Patients 6/17/2024
AstraZeneca’s Imfinzi Gets FDA Approval for Treating Endometrial Cancer
AstraZeneca’s Imfinzi Gets FDA Approval for Treating Endometrial Cancer 6/17/2024
Novo Nordisk CEO Agrees to Testify at Senate Hearing After Sanders’ Subpoena Threat
Novo Nordisk CEO Agrees to Testify at Senate Hearing After Sanders’ Subpoena Threat 6/17/2024
J&J’s $6.5B Momenta Buy Pays Off With Phase II Sjögren’s Disease Win
J&J’s $6.5B Momenta Buy Pays Off With Phase II Sjögren’s Disease Win 6/17/2024
Genetic Therapies Show Early Promise in Treating Obesity
Genetic Therapies Show Early Promise in Treating Obesity 6/17/2024
AI Enables Individualized Cancer Vaccines
AI Enables Individualized Cancer Vaccines 6/17/2024
FDA Action Alert: Merck, BMS, Sarepta and More
FDA Action Alert: Merck, BMS, Sarepta and More 6/17/2024
Opinion: Regulatory Flexibility Can Accelerate Rare Disease Drug Development
Opinion: Regulatory Flexibility Can Accelerate Rare Disease Drug Development 6/17/2024
Telix Abandons IPO Plans at Last Minute, Cites ‘Current Market Conditions’
Telix Abandons IPO Plans at Last Minute, Cites ‘Current Market Conditions’ 6/14/2024
J.P. Morgan Raises Over $500M for First Biotech Venture Capital Fund
J.P. Morgan Raises Over $500M for First Biotech Venture Capital Fund 6/14/2024
SCOTUS Upholds Access to Abortion Pill, Pharma Industry Applauds Court’s Ruling
SCOTUS Upholds Access to Abortion Pill, Pharma Industry Applauds Court’s Ruling 6/14/2024
GLP-1 Global Obesity Market to Reach $111B by 2033, Despite Headwinds: GlobalData
GLP-1 Global Obesity Market to Reach $111B by 2033, Despite Headwinds: GlobalData 6/14/2024
With Donanemab on the Cusp of Approval, Proper Alzheimer’s Diagnosis Is Urgent
With Donanemab on the Cusp of Approval, Proper Alzheimer’s Diagnosis Is Urgent 6/14/2024
BMS’ Augtyro Wins FDA Accelerated Approval for NTRK-Positive Solid Tumors
BMS’ Augtyro Wins FDA Accelerated Approval for NTRK-Positive Solid Tumors 6/14/2024
EU Says India’s Alchem Is Part of International Drug Price-Fixing Cartel
EU Says India’s Alchem Is Part of International Drug Price-Fixing Cartel 6/14/2024
Secondary Cancer Risk Is Low After CAR T Cell Treatment: Stanford Study
Secondary Cancer Risk Is Low After CAR T Cell Treatment: Stanford Study 6/13/2024
Moderna’s Next-Gen COVID Vaccine Beats Current Shot in Pivotal Adult Efficacy Trial
Moderna’s Next-Gen COVID Vaccine Beats Current Shot in Pivotal Adult Efficacy Trial 6/13/2024
Pfizer’s Gene Therapy for Duchenne Muscular Dystrophy Fails Phase III Trial
Pfizer’s Gene Therapy for Duchenne Muscular Dystrophy Fails Phase III Trial 6/13/2024
Santa Ana Bio Launches With $168M, Targets Autoimmune and Inflammatory Diseases
Santa Ana Bio Launches With $168M, Targets Autoimmune and Inflammatory Diseases 6/13/2024
Foresite Raises $900M in Sixth Fund to Invest in Life Science Startups
Foresite Raises $900M in Sixth Fund to Invest in Life Science Startups 6/13/2024
World Pharma News
- Novel drug application shows improved survival for patients with relapsed and refractory acute myeloid leukemia
- Study shows ancient viruses fuel modern-day cancers
- Darolutamide meets primary endpoint in Phase III ARANOTE trial
- Pfizer advances development of once-daily formulation of oral GLP-1 receptor agonist danuglipron
- New AI approach optimizes antibody drugs